WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr | ₹-0.66 Cr | ₹-0.51 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹-2.03 Cr |
Mar2022 | ₹-2.04 Cr |
Mar2021 | ₹0.68 Cr |
Mar2020 | ₹-0.66 Cr |
Mar2019 | ₹-0.51 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-2.03 Cr | Negative | |
Mar2022 | ₹-2.04 Cr | Negative | |
Mar2021 | ₹0.68 Cr | Positive | |
Mar2020 | ₹-0.66 Cr | Negative | |
Mar2019 | ₹-0.51 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,142.0 Cr | -0.6% | 5.6% | 118.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -0.6% |
5.6% |
118.2% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses